Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha-2 beta-2 gamma-2S subtype (GABA_A receptor α2β2γ2S)

Target
GABA_A receptor α2β2γ2S
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The GABA_A receptor α2β2γ2S subtype is a pentameric ligand-gated chloride channel that serves as a primary mediator of fast inhibitory neurotransmission in the central nervous system [1, 2]. It is typically composed of two α2, two β2, and one γ2S (short splice variant) subunits, forming a central pore that opens upon the binding of the neurotransmitter gamma-aminobutyric acid (GABA) [1, 5]. This specific subtype is highly expressed in brain regions such as the amygdala and hippocampus, where it plays a critical role in modulating emotional states, anxiety, and the brain's reward system [6, 11]. Pharmacologically, it is a major target for benzodiazepines, which act as positive allosteric modulators at the α/γ subunit interface to enhance GABAergic inhibition [4, 9]. Dysregulation or genetic variations of this receptor are linked to various neuropsychiatric conditions, including generalized anxiety disorder, epilepsy, and chronic pain [11, 12]. Consequently, it is a significant focus for the development of subtype-selective therapies aimed at providing anxiolytic and anticonvulsant effects with reduced sedative side effects compared to non-selective modulators [12, 13].

Other names
GABA(A) receptor alpha2beta2gamma2SGABRA2-GABRB2-GABRG2S complexAlpha-2 beta-2 gamma-2S GABA-A receptorIonotropic GABA receptor alpha2beta2gamma2S
02

Mechanism of action

Positive allosteric modulation of the chloride channel in response to GABA binding, increasing the frequency or duration of channel opening to induce membrane hyperpolarization.

03

Biological functions

Inhibitory neurotransmissionChloride ion transportSignal transductionRegulation of neuronal excitabilitySynaptic transmission
04

Disease associations

AnxietyEpilepsyInsomniaChronic painSchizophreniaAlcohol dependenceDepression
05

Safety considerations

SedationTolerancePhysical dependenceRespiratory depressionCognitive impairmentWithdrawal syndrome
06

Interacting drugs

Diazepam

9 more in the full profile.

07

Biomarkers

EEG beta-band activityPET imaging with [11C]flumazenilGABRA2 gene polymorphisms

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha-2 beta-2 gamma-2S subtype (GABA_A receptor α2β2γ2S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-2 beta-2 gamma-2S subtype (GABA_A receptor α2β2γ2S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call